Vanguard Personalized Indexing Management
OTLK icon

Vanguard Personalized Indexing Management’s Outlook Therapeutics OTLK Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.3K Sell
24,119
-7,373
-23% -$4.57K ﹤0.01% 2163
2026
Q1 		$6.48K Buy
31,492
+15,887
+102% +$6.87K ﹤0.01% 2163
2025
Q4 		$24.7K Buy
15,605
+1,713
+12% +$2.74K ﹤0.01% 1930
2025
Q3 		$14.7K Buy
13,892
+659
+5% +$1.14K ﹤0.01% 1973
2025
Q2 		$21.2K Buy
13,233
+1,937
+17% +$3.09K ﹤0.01% 1902
2025
Q1 		$13.8K Sell
11,296
-655
-5% -$1.15K ﹤0.01% 1811
2024
Q4 		$22.6K Buy
+11,951
New +$49.2K ﹤0.01% 1759

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Vanguard Personalized Indexing Management's OTLK Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Outlook Therapeutics (OTLK) stake by 23% in Q2 2026, selling an estimated $4.57K and leaving 24,119 shares worth $38.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Vanguard Personalized Indexing Management first reported a position in OTLK in Q4 2024 and has held it in 7 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Vanguard Personalized Indexing Management held 24,119 shares of Outlook Therapeutics worth $38.3K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 7,373 Outlook Therapeutics shares in Q2 2026, an estimated $4.57K.
  • Outlook Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2163 holding.
  • Vanguard Personalized Indexing Management first reported a position in Outlook Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.